Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apyx Medical Corporation stock logo
APYX
Apyx Medical
$2.13
$2.10
$0.76
$2.73
$80.55M1.43108,734 shs19,303 shs
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
$2.66
+2.3%
$2.48
$1.05
$12.50
$95.04M-0.98319,723 shs113,081 shs
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
$0.26
-6.0%
$0.25
$0.06
$0.32
$21.53M0.3214,295 shs13,414 shs
Nutriband Inc. stock logo
NTRB
Nutriband
$7.15
+6.1%
$7.12
$3.72
$11.78
$86.05M1.13131,905 shs21,094 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apyx Medical Corporation stock logo
APYX
Apyx Medical
+1.43%+3.40%-1.39%+21.02%+83.62%
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
+6.12%+5.26%+14.04%-63.38%+259,999,900.00%
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
0.00%-5.52%-0.36%+19.13%+44.21%
Nutriband Inc. stock logo
NTRB
Nutriband
-5.73%+7.67%+2.59%-13.03%+50.78%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apyx Medical Corporation stock logo
APYX
Apyx Medical
$2.13
$2.10
$0.76
$2.73
$80.55M1.43108,734 shs19,303 shs
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
$2.66
+2.3%
$2.48
$1.05
$12.50
$95.04M-0.98319,723 shs113,081 shs
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
$0.26
-6.0%
$0.25
$0.06
$0.32
$21.53M0.3214,295 shs13,414 shs
Nutriband Inc. stock logo
NTRB
Nutriband
$7.15
+6.1%
$7.12
$3.72
$11.78
$86.05M1.13131,905 shs21,094 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apyx Medical Corporation stock logo
APYX
Apyx Medical
+1.43%+3.40%-1.39%+21.02%+83.62%
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
+6.12%+5.26%+14.04%-63.38%+259,999,900.00%
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
0.00%-5.52%-0.36%+19.13%+44.21%
Nutriband Inc. stock logo
NTRB
Nutriband
-5.73%+7.67%+2.59%-13.03%+50.78%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apyx Medical Corporation stock logo
APYX
Apyx Medical
3.00
BuyN/AN/A
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
0.00
N/AN/AN/A
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
0.00
N/AN/AN/A
Nutriband Inc. stock logo
NTRB
Nutriband
3.00
Buy$13.0081.82% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apyx Medical Corporation stock logo
APYX
Apyx Medical
$46.51M1.73N/AN/A$0.38 per share5.61
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/AN/AN/AN/A
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
$10K2,152.67N/AN/A($0.12) per share-2.15
Nutriband Inc. stock logo
NTRB
Nutriband
$2.58M33.38N/AN/A$0.58 per share12.33
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apyx Medical Corporation stock logo
APYX
Apyx Medical
-$23.46M-$0.45N/AN/AN/A-37.11%-158.22%-28.30%11/7/2025 (Estimated)
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/A0.00N/AN/AN/AN/AN/A
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
-$2.42M-$0.05N/AN/AN/AN/A-219.85%11/12/2025 (Estimated)
Nutriband Inc. stock logo
NTRB
Nutriband
-$10.48M-$2.87N/AN/AN/A-398.29%-85.40%-73.45%12/2/2025 (Estimated)

Latest GTHP, BDMD, NTRB, and APYX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/9/2025Q2 2026
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.17-$2.12-$1.95-$2.12$0.71 million$0.62 million
8/14/2025Q2 2025
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
N/A-$0.01N/A-$0.01N/A$0.12 million
8/7/2025Q2 2025
Apyx Medical Corporation stock logo
APYX
Apyx Medical
-$0.0933-$0.09+$0.0033-$0.09$11.69 million$11.37 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apyx Medical Corporation stock logo
APYX
Apyx Medical
N/AN/AN/AN/AN/A
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/AN/AN/A
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
N/AN/AN/AN/AN/A
Nutriband Inc. stock logo
NTRB
Nutriband
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apyx Medical Corporation stock logo
APYX
Apyx Medical
4.61
4.72
3.95
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/A
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
N/A
0.13
0.03
Nutriband Inc. stock logo
NTRB
Nutriband
0.01
4.78
4.70

Institutional Ownership

CompanyInstitutional Ownership
Apyx Medical Corporation stock logo
APYX
Apyx Medical
55.33%
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
19.78%
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
9.69%
Nutriband Inc. stock logo
NTRB
Nutriband
19.70%

Insider Ownership

CompanyInsider Ownership
Apyx Medical Corporation stock logo
APYX
Apyx Medical
15.20%
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
78.90%
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
66.83%
Nutriband Inc. stock logo
NTRB
Nutriband
54.09%
CompanyEmployeesShares OutstandingFree FloatOptionable
Apyx Medical Corporation stock logo
APYX
Apyx Medical
27037.82 million32.07 millionOptionable
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/A35.73 million7.54 millionN/A
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
583.60 million27.73 millionNot Optionable
Nutriband Inc. stock logo
NTRB
Nutriband
1012.04 million5.53 millionNot Optionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Apyx Medical stock logo

Apyx Medical NASDAQ:APYX

$2.13 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$2.16 +0.03 (+1.60%)
As of 04:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Baird Medical Investment stock logo

Baird Medical Investment NASDAQ:BDMD

$2.66 +0.06 (+2.31%)
As of 04:00 PM Eastern

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

Guided Therapeutics stock logo

Guided Therapeutics OTCMKTS:GTHP

$0.26 -0.02 (-6.02%)
As of 03:31 PM Eastern

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

Nutriband stock logo

Nutriband NASDAQ:NTRB

$7.15 +0.41 (+6.08%)
Closing price 04:00 PM Eastern
Extended Trading
$6.98 -0.18 (-2.45%)
As of 04:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.